Marcoux et al.
JOCFeatured Article
of the crude mixture, and enantiomeric excess (95 and 83% ee)
was determined by SFC analysis on chiral phase (Chiralpak
OD-H 25 cm, 10% MeOH, 3 mL/min, 30 °C, 150 psi, tr (minor
trans) 6.7 min, tr (major trans) 7.9 min, tr (major cis) 9.3 min, tr
(minor cis) 12.6 min); mp 125-127 °C; Rf 0.25 (100%, EtOAc);
by SFC analysis on chiral phase (Chiralpak OD-H 25 cm, 5%
MeOH, 3 mL/min, 30 °C, 150 psi, tr (major) 10.2 min, tr (minor)
23.8 min); Rf 0.48 (100%, Et2O); mp 72-75 °C; [R]20D=þ116
(c 0.58, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.39-7.23 (m,
5H), 6.68 (d, J=15.9 Hz, 1H), 6.21 (dd, J=9.3 Hz, J=15.9 Hz,
1H), 3.75 (s, 3H), 3.54-3.50 (m, 3H), 3.41-3.37 (m, 1H), 2.62
(app q, J=9.3 Hz, J=15.6 Hz, 1H), 1.97-1.91 (m, 4H), 1.84 (dd,
J=4.8 Hz, J=7.5 Hz, 1H), 1.68 (dd, J=4.8 Hz, J=9.0 Hz, 1H);
13C NMR (75 MHz, CDCl3) δ 169.8, 166.4, 137.2, 133.3, 128.7
(2C), 127.6, 126.3 (2C), 125.7, 52.8, 46.8, 46.5, 37.8, 31.7, 26.2,
24.4, 21.5; IR (film) 3024, 2959, 2874, 1726, 1633, 1416, 1312,
1139 cm-1; HRMS (ES, Pos) calcd for C18H21N1O3 [M þ H]þ
300.1594, found 300.1596.
1
mp 180-183 °C; [R]20D=-26 (c 2.95, CHCl3); H NMR (300
MHz, CDCl3) δ (major þ minor) 8.05-8.00 (m, 1H), 7.89-7.85
(m, 1H), 7.78-7.65 (m, 5H), 7.63-7.55 (m, 1H), 7.35-7.09
(m, 10H), 3.74 (s, 3.74), 3.58-3.47 (m, 4H), 3.24-3.09 (m, 3H),
3.12 (s, 3H), 3.07-2.91 (m, 2H), 2.61-2.50 (m, 1H), 2.31 (s, 3H),
2.28 (s, 3H), 2.16-2.04 (m, 2H), 1.96-1.84 (m, 4H), 1.81 (dd, J=
5.1 Hz, J=8.1 Hz, 1H), 1.53 (dd, J=5.1 Hz, J=9.2 Hz, 1H),
1.45-1.33 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 171.1, 168.3,
166.2, 163.3, 135.4, 135.3, 135.1, 135.0, 131.3, 130.9, 130.0 (2C),
129.9 (2C), 127.1 (2C), 127.0 (2C), 125.7, 125.1, 125.0, 123.5,
123.4, 121.9, 120.3, 118.9, 118.0, 117.3, 113.9, 113.6, 53.6, 52.9,
52.3, 46.6, 46.4, 46.3, 45.8, 39.6, 38.2, 30.5, 26.2, 25.3, 24.3, 23.7,
23.0, 22.4, 21.7, 21.1, 17.9; IR (film) 3050, 3010, 2951, 2876,
1731, 1641, 1600, 1521, 1429, 1317, 1144, 870 cm-1; HRMS (ES,
Pos) calcd for C25H26N2O5S1 [M þ H]þ 467.1634, found
467.1635.
Methyl 2-(2,2-diphenylvinyl)-1-(pyrrolidine-1-carbonyl)cyclo-
propanecarboxylate (10ak). Prepared according to the general
procedure. The product was isolated as a white solid: yield 90%;
1
diastereomeric ratio (6:1) was determined by H NMR of the
crude mixture, and enantiomeric excess (75 and 53% ee) was
determined by SFC analysis on chiral phase (Chiralpak OD-H
25 cm, 7% i-PrOH, 2 mL/min, 35 °C, 150 psi, tr (minor trans)
15.7 min, tr (major trans) 18.8 min, tr (minor cis) 20.3 min, tr
(major cis) 23.4 min); mp 115-118 °C; Rf 0.45 (100%, Et2O);
Methyl 2-(1-benzyl-1H-indol-3-yl)-1-(pyrrolidine-1-carbonyl)-
cyclopropanecarboxylate (10ah). Prepared according to the
general procedure. The product was isolated as a colorless oil:
1
[R]20D=þ44 (c 1.83, CHCl3); H NMR (300 MHz, CDCl3) δ
(major) 7.51-7.21 (m, 10H), 6.13 (d, J=13.1 Hz, 1H), 3.79 (s,
3H), 3.42-3.31 (m, 3H), 3.20-3.09 (m, 1H), 2.64-2.53 (m, 1H),
1.97-1.63 (m, 6H), (minor) 7.51-7.21 (m, 10H), 5.44 (d, J=13.1
Hz, 1H), 3.69 (s, 3H), 3.45-3.34 (m, 3H), 3.34-3.19 (m, 1H),
2.81-2.70 (m, 1H), 1.97-1.63 (m, 6H); 13C NMR (75 MHz,
CDCl3) δ (major þ minor) 171.6, 171.5, 170.6, 167.0, 145.7,
145.6, 142.9, 142.7, 140.2, 140.0, 131.1 (2C), 130.7, 139.4, 129.2
(2C), 129.1, 128.9 (2C), 128.4, 128.4, 128.3, 128.2 (2C), 128.1,
128.0, 126.1, 125.2, 53.5, 53.4, 47.3, 47.2, 47.1, 47.0, 38.7, 38.4,
29.9, 29.2, 26.9, 26.7, 26.9, 26.7, 25.1, 24.9, 23.7, 23.1; IR (film)
3057, 3010, 2952, 2877, 1726, 1639 cm-1; HRMS (ES, Pos) calcd
for C24H25N1O3 [M þ H]þ 376.1907, found 376.1919.
1
yield 88%; diastereomeric ratio (1.5:1) was determined by H
NMR of the crude mixture, and enantiomeric excess (50 and
41% ee) was determined by SFC analysis on chiral phase
((major) Chiralpak AD-H 25 cm, 20% MeOH, 3 mL/min,
35 °C, 150 psi, tr (minor) 5.7 min, tr (major) 12.2 min; (minor)
Chiralpak AD-H 25 cm, 20% MeOH, 3 mL/min, 35 °C, 150 psi,
tr (minor) 3.7 min, tr (major) 4.2 min); Rf 0.25 (100%, Et2O);
1
[R]20D=þ39 (c 1.25, CHCl3); H NMR (300 MHz, CDCl3) δ
(Major) 7.80 (d, J=8.8 Hz, 1H), 7.78-6.93 (m, 9H), 5.29-5.23
(m, 2H), 3.61-3.3.52 (m, 3H), 3.39 (app t, J = 8.7 Hz, 1H),
3.30-3.20 (m, 4H), 2.08 (dd, J = 4.9 Hz, J = 8.0 Hz, 1H),
1.95-1.83 (m, 4H), 1.57 (dd, J=4.9 Hz, J=9.2 Hz, 1H), (minor)
7.77 (d, J=8.8 Hz, 1H), 7.48-7.07 (m, 8H), 6.84 (s, 1H), 5.24
(dd, J=4.5 Hz, J=9.2, 2H), 3.79 (s, 3H), 3.40 (app t, J=8.9 Hz,
1H), 3.33-3.14 (m, 2H), 3.08-2.94 (m, 1H), 2.77-2.70 (m, 1H),
2.14 (dd, J=4.9 Hz, J=8.0 Hz, 1H), 1.88 (dd, J=4.9 Hz, J=9.2
Hz, 1H), 1.57-1.35 (m, 3H), 0.52-0.37 (m, 1H); 13C NMR (75
MHz, CDCl3) δ (major) 169.0, 166.9, 137.9, 136.6, 129.0, 128.9
(2C), 127.7, 127.3, 126.9 (2C), 122.0, 119.8, 119.5, 110.2, 109.7,
52.3, 50.1, 46.6, 46.5, 38.4, 26.2, 24.4, 23.7, 18.6; IR (film) 2949,
2874, 1726, 1630, 1432, 1308, 1145, 732 cm-1; HRMS (ES, Pos)
calcd for C25H26N2O3 [M þ H]þ 403.2016, found 403.2031.
Methyl 2-butoxy-1-(pyrrolidine-1-carbonyl)cyclopropanecar-
boxylate (10ai). Prepared according to the general procedure
using the alkene with a 10-fold excess. The product was isolated
as a colorless oil: yield 70%; diastereomeric ratio (89:11) was
determined by 1H NMR analysis of the crude mixture, and
enantiomeric excess (89% ee) was determined by SFC analysis
on chiral phase (R,R-Welko 25 cm, 7% MeOH, 3 mL/min,
40 °C, 160 psi, tr (minor) 10.3 min, tr (major) 15.7 min); Rf 0.38
Methyl 2-((E)-1-phenylprop-1-en-2-yl)-1-(pyrrolidine-1-carbonyl)-
cyclopropanecarboxylate (10al). Prepared according to the gen-
eral procedure. The product was isolated as a colorless oil: yield
73%; diastereomeric ratio (14:1) was determined by 1H NMR of
the crude mixture, and enantiomeric excess (85% ee) was
determined by SFC analysis on chiral phase (Chiralpak AD-H
25 cm, 3% MeOH, 3 mL/min, 40 °C, 150 psi, tr (major) 5.7 min,
tr (minor) 6.9 min); Rf 0.33 (100%, Et2O); [R]20D=-83 (c 1.08,
CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.35-7.12 (m, 5H), 6.36
(s, 1H),3.63 (s, 3H), 3.60-3.39 (m, 3H), 3.29-3.17 (m, 1H), 2.85
(app t, J=9.2 Hz, 1H), 2.03 (dd, J=4.8 Hz, J=8.1 Hz, 1H),
1.96-1.78 (m, 7H), 1.32 (dd, J=4.8 Hz, J=8.7 Hz, 1H); 13C
NMR (75 MHz, CDCl3) δ 169.1, 166.6, 137.9, 132.4, 129.0 (2C),
128.5, 128.3 (2C), 126.5, 52.6, 46.7, 46.4, 37.8, 35.7, 30.5, 26.3,
24.3, 18.6; IR (film) 3057, 3010, 2952, 2877, 1726, 1639 cm-1
;
HRMS (ES, Pos) calcd for C19H23N1O3 [M þ H]þ 314.1756,
found 314.1760.
Methyl 2-((E)-2,6-dimethylhepta-1,5-dienyl)-1-(pyrrolidine-1-
carbonyl)cyclopropanecarboxylate (10am). Prepared according
to the general procedure. The product was isolated as a colorless
oil: yield 45%; diastereomeric ratio (22:1) was determined by
1H NMR of the crude mixture, and enantiomeric excess (90%
ee) was determined by SFC analysis on chiral phase (Chiralpak
AD-H 25 cm, 5% MeOH, 10 mL/min, 40 °C, 150 psi, tr (minor)
3.9 min, tr (major) 5.2 min); Rf 0.54 (100%, Et2O); [R]20D=-32
(c 2.70, CHCl3); 1H NMR (300 MHz, CDCl3) δ 5.05-5.00 (m,
2H), 3.67 (s, 3H), 3.53-3.39 (m, 3H), 3.29-3.15 (m, 1H),
2.52-2.50 (m, 1H), 2.10-1.76 (m, 8H), 1.74 (s, 3H),
1.67-1.60 (m, 4H), 1.56 (s, 3H), 1.43 (dd, J = 4.5 Hz, J =
9.0 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 169.9, 166.8, 140.7,
131.6, 124.1, 119.7, 52.4, 46.5, 46.3, 39.7, 37.6, 27.1, 26.7, 26.1,
25.8, 24.3, 21.1, 17.8, 16.8; IR (film) 2970, 2890, 1729, 1643,
1
(100%, Et2O); [R]20D = þ64 (c 0.91, CHCl3); H NMR (300
MHz, CDCl3) δ 4.09 (dd, J=5.4 Hz, J=7.0 Hz, 1H), 3.76 (s,
3H), 3.65-3.60 (m, 1H), 3.56-3.42 (m, 3H), 3.26-3.23 (m, 1H),
2.06 (app t, J=5.4 Hz, 1H), 1.97-1.86 (m, 4H), 1.58-1.51 (m,
2H), 1.37-1.22 (m, 4 H), 0.90 (t, J=7.4 Hz, 3H); 13C NMR (75
MHz, CDCl3) δ 168.0, 165.8, 71.5, 64.1, 52.7, 46.4, 46.2, 37.1,
31.6, 26.1, 24.3, 20.3, 19.4, 14.0; IR (film) 2955, 2873, 1732, 1634,
1433, 1307, 1147 cm-1; HRMS (ES, Pos) calcd for C14H23N1O4
[M þ H]þ 270.1700, found 270.1703.
Methyl 1-(pyrrolidine-1-carbonyl)-2-styrylcyclopropanecarboxy-
late (10aj). Prepared according to the general procedure. The
product was isolated as a white solid: yield 77%; diastereomeric
1
ratio (9:1) was determined by H NMR analysis of the crude
mixture, and enantiomeric excess (87% ee) was determined
8954 J. Org. Chem. Vol. 74, No. 23, 2009